Covid-19 roundup: Poland refuses to pay for more vaccine doses, triggering legal fight; Pfizer, Moderna face more investor pressure to open up mRNA tech

Amber Tong

Poland says it will not pay for more Covid-19 vaccine doses under the EU’s supply contract, potentially setting up a legal fight with vaccine makers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Poland refuses to pay for more vaccine doses, triggering legal fight; Pfizer, Moderna face more investor pressure to open up mRNA tech

Amber Tong

Sign up to read this article for free.

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Sanofi introduces new 340B payment model — report

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Poland re­fus­es to pay for more vac­cine dos­es, trig­ger­ing le­gal fight; Pfiz­er, Mod­er­na face more in­vestor pres­sure to open up mR­NA tech

Amber Tong

Sign up to read this article for free.

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Covid-19 roundup: Poland refuses to pay for more vaccine doses, triggering legal fight; Pfizer, Moderna face more investor pressure to open up mRNA tech

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Sanofi introduces new 340B payment model — report

Are programs with compounded GLP-1s safe for your population?